Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trialResearch in context

• Main Authors: Lei Tian (Author), Xiuming Jin (Author), Jibing Wang (Author), Yonggen Xu (Author), Chengwei Lu (Author), Shaozhen Zhao (Author), Qian Zhu (Author), Hong Dai (Author), Hao Gu (Author), Mingchang Zhang (Author), Linnong Wang (Author), Xiaohe Lu (Author), Lixiao Ma (Author), Lei Zhu (Author), Qingyan Zeng (Author), Hong Zhang (Author), Yao Fu (Author), Suxia Li (Author), Liming Tao (Author), Qian Ren (Author), Faming Ding (Author), Shenglin Zhang (Author), Shaopin Zhu (Author), Zhiping Li (Author), Ying Jie (Author)
• Format: Book
• Published: Elsevier, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Dry eye disease has a high prevalence and exerts a significant negative effect on quality of life. In China, there are currently no available nasal sprays to promote natural tear production in patients with dry eye disease. We therefore evaluated the efficacy and safety of OC-01...